Trial NCT03578198

View at ClinicalTrials.gov 
Org. Study IDs: Truximab+MG4101

Last trial update was posted on 2022-10-27

MeSH Interventions

Rituximab

MeSH Conditions

Lymphoma Lymphoma, Non-Hodgkin

Other Conditions

CD20-positive Non-Hodgkin Lymphoma

Stopping Reasons

Issues in supply of IP

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID